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ABSTRACT: The schedule of NMDA receptor sub-
unit expression and the appearance of functional
NMDA-gated ion channels were investigated during the
retinoic acid (RA) induced neuronal differentiation of
NE-4C, a p53-deficient mouse neuroectodermal progen-
itor cell line. NR2A, NR2B, and NR2D subunit tran-
scripts were present in both nondifferentiated and neu-
ronally differentiated cultures, while NR2C subunits
were expressed only transiently, during the early period
of neural differentiation. Several splice variants of NR1
were detected in noninduced progenitors and in RA-
induced cells, except the N1 exon containing transcripts
that appeared after the fourth day of induction, when
neuronal processes were already formed. NR1 and
NR2A subunit proteins were detected both in nondiffer-
entiated progenitor cells and in neurons, while the ma-
ture form of NR2B subunit protein appeared only at the
time of neuronal process elongation. Despite the early
presence of NR1 and NR2A subunits, NMDA-evoked
responses could be detected in NE-4C neurons only after
the sixth day of induction, coinciding in time with the
expression of the mature NR2B subunit. The formation
of functional NMDA receptors also coincided with the
appearance of synapsin I and synaptophysin. The lag
period between the production of the subunits and the
onset of channel function suggests that subunits capable
of channel formation cannot form functional NMDA
receptors until a certain stage of neuronal commitment.
Thus, the in vitro neurogenesis by NE-4C cells provides
a suitable tool to investigate some inherent regulatory
processes involved in the initial maturation of NMDA
receptor complexes. © 2002 Wiley Periodicals, Inc. J Neurobiol
51: 54–65, 2002; Published online in Wiley InterScience (www.interscience.
wiley.com). DOI 10.1002/neu.10049
Keywords: cell line; progenitor; NR1 splice variants;
NR2 subunits; neuronal development
INTRODUCTION
NMDA (N-methyl-D-aspartate) gated ion channels—a
subtype of ionotropic glutamate receptors—play im-
portant roles in excitatory neurotransmission, neuro-
nal survival, excitotoxicity, synapse formation as well
as in the processes of learning and memory (Balazs et
al., 1988; Scheetz and Constantine-Paton, 1994; Val-
lano, 1998). The NMDA receptor comprises subunits
from two gene families, designated NR1 and NR2 (or
GluR and GluR, respectively) (Mori and Mishina,
1995). Some data has also been published on the
involvement of a third subclass of subunits, NR3
(Ciabarra et al., 1995; Sucher et al., 1995). In NR1
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gene products one N-terminal (N1 or exon 5) and two
C-terminal exons (C1 or exon 21 and C2 or exon 22)
can be transcribed independently, leading to the for-
mation of eight splice variants (Sugihara et al., 1992;
Hollmann et al., 1993). The NR2 gene family codes
four distinct types of subunits called NR2A-D (or
GluR1–4) (Monyer et al., 1992; Nakanishi, 1992).
Functional NMDA receptors are heteromeric com-
plexes, containing at least one NR1 and one or more
types of NR2 subunits (Mori and Mishina, 1995). The
subunit composition influences the functional proper-
ties as well as the intracellular and cell surface local-
ization of the receptor complexes (Ehlers et al., 1998;
McIlhinney et al., 1998; Okabe et al., 1999; Ya-
makura and Shimoji, 1999; Perez-Otano et al., 2001).
In the course of neural tissue-genesis, the pattern of
NR1 and NR2 subunit expression reflects both re-
gional determination and temporal shifts in develop-
ment (Watanabe et al., 1992; Laurie and Seeburg,
1994; Monyer et al., 1994). NR2B and NR2D mRNAs
are expressed predominantly in the embryonic brain.
NR2A mRNAs appear in the entire brain after birth,
while NR2C mRNAs are expressed postnatally, pri-
marily in the cerebellum. In postnatal rodent brain,
NR2B transcripts are restricted principally to the fore-
brain, and the level of NR2D mRNAs is greatly
decreased throughout the whole brain. Consequently,
neurons can display functionally different NMDA
receptor complexes during development and matura-
tion (Williams et al., 1993; Feldmeyer and Cull-
Candy, 1996; Vallano, 1998).
Although progenitor cells of the early embryonic
nervous system are not available for molecular anal-
yses, one-cell-derived neuroectodermal progenitor
cell lines can provide appropriate in vitro models to
understand the importance of the subunit composition
of NMDA receptors and to investigate the time sched-
ule of the subunit expression during some early
phases of neuronal commitment and differentiation.
NE-4C cell line, derived from forebrain vesicles of
9-day-old p53-deficient mouse embryos, provides a
well-established model to study in vitro neuron for-
mation (Schlett and Madarasz, 1997; Schlett et al.,
1997). Neuronal differentiation of NE-4C cells can be
induced by treatment with all-trans retinoic acid. The
first immature neurons appear on the third to fourth
day of RA treatment, and dense networks of neuronal
processes are formed by the end of the first week of
induction. Morphological maturation, changes in the
expression of intermediate filaments, the production
of neuron-specific markers and the development of
bioelectrical properties have been thoroughly investi-
gated and led to the description of a reproducible time
table of in vitro neurogenesis (Schlett and Madarasz,
1997; Schlett et al., 1997; Jelitai et al., 2000).
In this study, the expression of various NMDA
receptor subunits and the appearance of functional
NMDA gated ion channels were investigated and
correlated with defined stages of RA-induced neuro-
nal differentiation of NE-4C cells. Some parts of the
work have been presented as conference abstracts
(Jelitai et al., 2000; Schlett et al., 2000).
METHODS
Maintenance of the NE-4C Cell Line
NE-4C cells were grown in Minimum Essential Medium
(MEM; Sigma) supplemented with 5% fetal calf serum
(FCS, Gibco), 4 mM glutamine (Sigma-Aldrich Co, Hun-
gary) and 40 g/mL gentamycin (Sigma-Aldrich Co, Hun-
gary), at 37°C with 5% CO2. Subconfluent cultures were
regularly transferred by trypsinization [0.05% trypsin (Sig-
ma-Aldrich Co, Hungary) in phosphate buffer saline (PBS)]
and replated at 104 cells/cm2 cell density into poly-L-lysine
(PLL) (Sigma-Aldrich Co, Hungary)-coated dishes.
Treatment with all-trans Retinoic Acid
(RA)
102 M stock solution of all-trans retinoic acid (Sigma-
Aldrich Co, Hungary) dissolved in DMSO was stored under
liquid N2. 104 M working solution of RA (dissolved in
MEM) was stored in dark at 80°C, and was diluted
directly to the final 106 M concentration into the medium
of the cells. Cells were seeded at 2.5  104 cells/cm2
density onto poly-L-lysine-coated surfaces and were in-
duced to differentiate by a 48-h treatment with RA. Cultures
were maintaned without RA from the third day of induction.
Semiquantitative RT-PCR Analysis
Total RNA from nondifferentiated and RA treated NE-4C
cells was isolated using Trizol-LS (Gibco BRL), while total
RNA from the cerebella and the forebrains of 30-day-old
C57/Bl6 mice was isolated by PeqGold RNAPure
(PEQLAB Biotech.; Erlangen, Germany) according to the
manufacturer’s recommendations. After digestion with
RNase-free DNase I (Boehringer, Germany) at 37°C for 15
min, 3 g RNA was reverse-transcribed using the First
Strand cDNA Synthesis Kit (MBI Fermentas, St. Leon-Rot,
Germany) both with random hexamer and oligodT primers,
according to the manufacturer’s instructions. Negative con-
trols consisted of the same reaction mixture except that
reverse transcriptase was omitted. PCR reactions were car-
ried out in a PTC-200 Peltier Thermal Cycler (MJ Re-
search), using HotStarTaq polymerase (Qiagen; Hilden,
Germany; 1 U/50 L PCR reaction mixture). The primer
sets used for the PCR analyses are listed in Table 1. The
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reaction mixture contained 2.5 mM MgCl2, 0.4 mM dNTPs
(PEQLAB Biotech.; Erlangen, Germany) and 0.4 M of
each primer for primer sets 1 and 8, and 1.5 mM MgCl2, 0.2
mM dNTPs and 0.2 M of each primer for primer sets 2–7
(see Table 1). PCR temperature protocols were consisted of
an initial activation of the HotStarTaq polymerase at 95°C
for 15 min, followed either by 40 cycles with 94°C 1 min,
72°C 2 min (primer sets 1, 3, and 7), 40 cycles with 94°C 1
min, 62°C 45 s, 72°C 2 min (primer set 2), 40 cycles with
94°C 45 s, 67°C 1 min, 72°C 1 min (primer set 4 and 5), 40
cycles with 94°C 1 min, 63°C 1 min, 72°C 1 min (primer set
6) or 30 cycles with 94°C 1 min, 55°C 1 min, 72°C 1 min
(primer set 8). A final elongation period of 10 min at 72°C
was included in all PCR protocols. The reactions were set in
a way to maintain linear transcript amplification during the
PCR reactions. Forebrain cDNA samples were used as
positive controls except in the case of NR2C subunit detec-
tion, where cerebellar cDNA was included. PCR products
were analyzed on 2% agarose gel stained with ethidium-
bromide.
Each experiment was repeated a minimum of three times
with cDNAs from independent RT reactions using either
random hexamer or oligo dT primers. To be sure that the
observed mRNA expression patterns are typical during the
differentiation of NE-4C, a second set of cDNA samples
from independent NE-4C cultures was also reverse tran-
scribed with oligo dT primers, and the PCR reactions were
repeated. In all cases, the results were concordant. For better
visualization, representative negative images are presented
on Figure 1.
Protein Sample Preparation
NE-4C cells were harvested with Ca2, Mg2-free PBS
containing 0.1% EDTA, and collected by centrifuging at
800  g. Unless indicated, all steps were carried out on ice.
Cell-containing pellets were stored at 80°C until use. For
subcellular fractionation, pellets were lysed using a hand-
operated pestle (Sigma, Germany) in 10 mM HEPES, 250
mM sucrose containing buffer (pH  7.4) supplemented
with 0.5 mM phenylmethyl-sulfonyl fluoride, 10 g/mL
leupeptine, 2 g/mL aprotinin, and 10 M bestatin. Nuclei
were removed by centrifugation at 2000  g for 5 min, and
supernatants were centrifuged at 16,000  g for 30 min.
The resulting pellet was enriched in mitochondria and larger
membrane particles (crude membrane fraction), while the
supernatant contained microsomal fraction and soluble
components of the cytoplasm (cytoplasmic fraction). Pellets
were homogenized in 150 mM NaCl, 10 mM HEPES con-
taining buffer (pH  7.4) supplemented with protease in-
hibitors (as above). Protein extracts from forebrains and
cerebella of 2-month-old C57/Bl6 mice were prepared by
homogenization in 8–10 volumes of ice-cold buffer con-
taining 0.32 M sucrose, 1 mM NaHCO3, 1 mM MgCl2, 0.5
mM CaCl2, and protease inhibitors (as above), using a
Potter homogenizer with 12 strokes at 800 rpm. Brain
homogenates were centrifuged at 1400  g for 10 min, and
supernatants were used for Western blot analyses. Protein
content of the samples was determined according to Brad-
ford (Bradford, 1976).
Table 1
Set Subunit Primer Sequences
Position
(bp) Expected Size (bp)
1 NR1 N1 exon Forward 5gacaagagcatccacctgagcttcc3 481–505 360 bp (N1)
Reverse 5agcgtcgtcctcgcttgcagaaagg3 777–753 297bp (N1)




Forward 5atgcccctgccaccctcacttttg3 2501–2524 381bp (C1, C2)
Reverse 5gcagctggccctcctccctctca3 2881–2859 270bp (C1, C2)
4 NR2A Forward 5ggagaagggtactccagcgctgaac3 81–105 280 bp
Reverse 5agtctgtgaggagataaaatccagc3 360–335
5 NR2B Forward 5gcaagcttctgtcatgctcaacatc3 456–480 220 bp
Reverse 5gctctgcagcttcttcagctgattc3 675–651
6 NR2C Forward 5actccttggtgcttgggcagg3 811–831 421 bp
Reverse 5cagcacctgcagctgctgctc3 1231–1211
7 NR2D Forward 5cttggctcctccacagagcaacagc3 481–505 298 bp
Reverse 5cctcttctgccgcccggaaaacagg3 778–754
8 GAPDH Forward 5tgatgacatcaagaaggtggtgaag3 805–829 240 bp
Reverse 5tccttggaggccatgtaggccat3 1044–1022
Primer sets used for the amplification of NMDA receptor subunit mRNAs. The annealing position for each of the NR1 primer sets (1–3)
is relative to the sequence of Yamazaki et al., (1992). Set 1 detects NR1 mRNAs both with and without the N1 (exon5) splice casette (367
bp and 297 bp, respectively). Set 2 detects NR1 mRNAs with the C1 (exon 21) splice casette. Set 3 gives a positive PCR reaction only if the
C2 (exon22) splice casette is expressed—the larger and smaller fragments refer to the presence or absence of the C1 (exon 21) splice casette,
respectively. The EMBL/GenBank accession numbers of the sequences used to design the primers are as follows: NM_008169, NM_008170,
NM_008171, NM_010350, NM_008172, and M32599 (primer set 1–3, 4, 5, 6, 7, and 8, respectively). Sets 2 and 3 are taken from Liesi et
al. (1999).
56 Jelitai et al.
Western Blot Analysis
Equal amounts of protein samples (10 g protein in the case
of NR1 and 60 g protein in the case of NR2 subunits)
dissolved in Laemmli buffer (Laemmli, 1970) were loaded
onto 7.5% polyacrylamide gels, separated by SDS-PAGE
and transferred to nitrocellulose membrane (Immobilon
NC-pure, Millipore, Hungary; or Hybond ECL extra, Am-
ersham, Germany). Nonspecific antibody binding was
blocked by incubating with 0.05% Tween-20 and 3% nonfat
milk powder in TBS (Tris-buffered saline) for 1 h. Mem-
branes were incubated overnight at 4°C with the primary
antibodies listed in Table 2. After three washes with TBS
containing 0.05% Tween-20 (TBST), blots were incubated
with anti-rabbit, anti-mouse, or anti-goat IgGs conjugated
with either alkaline phosphatase (for colorimetric detection;
Jackson ImmunoResearch Laboratories, USA) or horse rad-
ish peroxidase (for chemiluminescence detection; Pierce,
Rockford, USA) in a dilution of 1:10,000 for 1 h. After
washing three times with TBST, antibody binding was
visualized either by 5-bromo-4-chloro-3-indolyl phosphate
(Sigma; 0.165 mg/mL) and nitro blue tetrazolium (Sigma;
0.33 mg/mL) dissolved in a buffer containing 0.1 M Trizma-
Base, 5 mM MgCl2, and 0.1 M NaCl, pH  9.5, or using
ECL chemiluminescence detection system (Amersham,
Germany).
Immunocytochemical Staining
Cells grown on PLL-coated coverslips in 24-well plates
were fixed with 4% paraformaldehyde (Taab, UK; w/v in
PBS) for 20 min, at room temperature (RT). After rinsing,
cells were permeabilized with 0.1% Triton X-100 in PBS
for 5 min. For staining with antibodies against NR1, NR2A,
or NR2B generously provided by Prof. Watanabe (Hok-
kaido University, Japan), 2–3 min of 1 mg/mL pepsin
pretreatment (dissolved in 0.2 N HCl) at 37°C was under-
taken. Nonspecific antibody binding was blocked by incu-
bating with 2% BSA (bovine serum albumin) in PBS for 1 h
at RT. Primary antibodies (see Table 2) were applied over-
night at 4°C. Fluorescent detection was carried out by
incubation either with biotinilated anti-mouse or anti-rabbit
IgGs (1:500, 1 h; Vector Laboratories) followed by Fluo-
rescein-conjugated Avidin D (1:1000, 1 h; Vector Labora-
tories) or with FITC labeled anti-mouse or anti-rabbit anti-
bodies (1:500, 1 h; Sigma). Preparations were mounted with
Mowiol 4.88 (Polysciences, Germany) and were investi-
gated under a Leitz Laborlux K microscope equipped with
fluorescent optics. For viewing under a light microscope,
biotin-labeled secondary antibodies were applied for 1 h
followed by the addition of ABC complex (Vector Labora-
tories) and were visualized by the 3-3-diamino-benzidine
(DAB, 0.55 mg/mL; Sigma) reaction in the presence of
0.3% H2O2.
Measurement of Intracellular Free
Calcium ([Ca2]I) Level in Single Cells
NE-4C cells grown on PLL-coated glass coverslips in
35-mm dishes were washed with Mg2-free physiological
solution (NaCl 140 mM, KCl 4.7 mM, CaCl2 2.6 mM,
HEPES 10 mM, D-glucose 10 mM, glycine 10 M, pH
 7.2) and loaded with 5 M Fura-2/AM (Molecular
Probes, Eugene, OR) for 45 min in a CO2-incubator at 37°C
in the above buffer solution. At the end of the incubation,
cultures were washed and incubated for a further 30 min to
ensure full hydrolysis of the Fura-esther. [Ca2]I was de-
termined at 37°C by a PTI (South Brunswick, NJ) mi-
crospectrofluorimeter fitted to an inverted Nikon TDM Dia-
phot epifluorescent microscope equipped with Fluor
objectives (Nikon, Japan) and a thermo-regulated sample
chamber. Fluorescence of single cells emitted in response to
excitation at 340 and 380 nm was measured at 510 nm by a
photomultiplier (D104 Microscope Photometer, PTI, South
Brunswick, NJ). Drugs (100 M NMDA, 10 M nifedipine,
500 M DL-AP5, 1 M -conotoxin, all from Tocris, UK)
were added for 20 s via a pressure ejection system. Data
were evaluated by a softwer (Felix) provided by PTI.
Figure 1 Expression of various NMDA receptor subunit
mRNAs in NE-4C cells at different stages of RA-induced
differentiation. Samples were taken from non-differentiated
(0 day) or from RA-treated cultures on the second, fourth,
sixth, eighth, or 11th days, respectively. The primer sets
used for amplification are listed in Table 1. The signs
adjoining the arrows indicate the existence () or absence
() of the different exons (N1, C1, or C2, respectively).
GAPDH-transcripts (glycerol-aldehyde-phosphate dehydro-
genase) were amplified to show the comparable amounts of
cDNA in the samples. cDNA isolated from 30-day-old
mouse forebrain was used as positive control () except in
the case of NR2C subunit detection, when cerebellar cDNA
was used. Negative control () included a mixture of
NE-4C samples prepared without reverse transcriptase.
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RESULTS
The Expression of NR1 and NR2 NMDA
Receptor Subunit mRNAs during In Vitro
Induced Neuronal Differentiation
Neuronal differentiation of NE-4C embryonic neuro-
ectodermal progenitor cells was induced by all-trans
retinoic acid (RA). Semiquantitative assays were used
to monitor the changes in the level of NMDA receptor
subunit mRNAs expressed in different stages of reti-
noic acid-induced neuronal differentiation. Total
RNA samples obtained from NE-4C cells at different
stages of neuronal differentiation were analyzed by
RT-PCR (Fig. 1).
NR1 transcripts were detected with three different
sets of primers, each recognizing distinct splice vari-
ants (Table 1). Assays with primers detecting all vari-
ants of NR1 mRNAs (set 1 in Table 1) showed that
the total amount of NR1 transcripts was highly ele-
vated by retinoic acid treatment. Nondifferentiated
NE-4C cells expressed mRNA containing C1 (exon
21) and/or C2 (exon 22) but variants containing the
N-terminal N1 exon (exon 5) were not detected. The
proportion of the different splice variants changed
with the advancement of neuronal differentiation: the
amount of mRNAs containing C2 but lacking C1 exon
increased in comparison to those containing both C1
and C2 exons. The N1 exon cassette appeared only 4
days after the addition of RA, and the quantity de-
tected was highly elevated after the first week of
induction. NR2A, NR2B, and NR2D transcripts were
present in both nondifferentiated and differentiated
cells. The level of NR2D transcripts was consistently
high during the whole induction period, while the
level of NR2A mRNAs increased after the sixth day
of induction. NR2B mRNA level was very low in
nondifferentiated cells but elevated steadily with the
advancement of differentiation. NR2C subunit
mRNAs were detectable only transiently: a 2-day
treatment with retinoic acid-induced NR2C expres-
sion strongly but the quantity of detectable transcripts
became negligible by the eighth day of induction.
NR1 Subunit Protein Was Detected Both
in Nondifferentiated and Neuronally
Differentiated NE-4C Cells
To detect the presence of NR1 subunit proteins, cy-
toplasmic and crude-membrane fractions of NE-4C
cells were prepared at different stages of neural dif-
ferentiation and were analyzed on Western blots using
two different antibodies [Fig. 2(A)]. The apparent







NR1 4–51 rabbit Watanabe, 1998
(GluR1N)
0,5 g/mL 0,5 g/mL








NR2A last 200 rabbit Upstate Biotech.
(06-313)
1:3000 1:1000
NR2A 1126–1408 rabbit Watanabe, 1998
(GluR1C)
— 0,5 g/mL
NR2B 1325–1461 mouse Laurie, 1997
(BM 1B3.3B6)
1:10000 —
NR2B 1–48 rabbit Watanabe, 1998
(GluR2N)
— 0,25 g/mL
NR2C C terminal rabbit Chemicon
(AB1592P)
1:1000 —








Synapsin I C terminal mouse Chemicon
(MAB355)
— 1:2000
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molecular weight of the NR1 protein produced by
NE-4C cells corresponded to that found in adult fore-
brain samples that were used as positive controls. One
of the antibodies produced against the N-terminal
4–51 amino acids of mouse NR1 subunit protein
(Watanabe et al., 1998) recognized all NR1 splice
variants. The antibody stained double bands in the
forebrain homogenates that may correspond to the
relatively high level of different NR1 splice variants
in adult forebrain [Fig. 2(A)]. The other antibody
reacting with the C-terminal 891–920 amino acids
(Chemicon Int., Ltd) was specific to the C2 exon
cassette containing protein form (Table 2), and gave a
specific band at an apparent molecular weight of 116
kDa.
NR1 subunits were readily detected by both anti-
bodies in 10 g protein samples. In the cytoplasmic
fraction, the amount of NR1 protein did not change in
the course of retinoic acid induced differentiation
[Fig. 2(A)]. In the crude membrane fraction, on the
other hand, less NR1 protein was detected and the two
antibodies revealed different distribution patterns.
While NR1 subunit protein was found in samples
prepared from both noninduced and differentiated
NE-4C cells, the C2 cassette containing NR1 protein
was hardly detectable in the crude membrane fraction
of noninduced cultures, and its amount was limited
even on the eighth day of induction.
To visualize the distribution of NR1 subunit pro-
tein, NE-4C cells were immunostained either with the
N-terminal specific antibody (Watanabe et al., 1998)
or with a monoclonal antibody directed against amino
acids 660–811 between the III–IV transmembrane
domain (PharMingen Ltd; Table 2). Both antibodies
recognized all variants of NR1 subunits and gave
similar, dot-like immunostaining [Fig. 2(B)–(C)]. In
noninduced progenitor cells [Fig. 2(B)], immunoreac-
tivity was localized in the perinuclear region, in a
rather nonhomogeneous pattern. In retinoic acid-
treated cultures, neuron-like cells displayed strong,
evenly distributed immunoreactivity both in the
perykarion and along the neurites [Fig. 2(C)].
NR2A Subunit Protein Was Present Both
in Noncommitted Progenitors and in
RA-Induced Neurons
To detect NR2A subunit protein by Western blotting,
a C-terminal specific antibody raised against the last
200 amino acids of the C-terminus of mouse NR2A
(Upstate Biotech.) was used (Table 2). In mouse fore-
brain samples, a single band with an apparent molec-
ular weight of 170 kDa was strongly stained [Fig.
3(A)]. The same specific band was detected in all
NE-4C samples but at a very low level. Specific
signals were detected only if 60 g or more protein
was loaded indicating that the relative amount of
NR2A protein in NE-4C cells was low.
In noninduced cells and in cells on the second day
of RA induction, the majority of the detectable NR2A
protein was found in the crude membrane fraction.
After the fourth day, the amount of NR2A protein was
markedly elevated in the cytoplasmic fraction. Similar
signal intensity in the crude membrane fraction was
found only on the ninth day of induction. An NR2A-
immunreactive protein band with lower molecular
weight was present in all samples throughout the
induction period. The presence of the immunoreactive
band at about 160 kDa suggested that some immature
Figure 2 Expression of NR1 subunit proteins in NE-4C
cells at different stages of RA-induced differentiation. (A)
Western blot detection of NR1 subunit protein in subcellular
fractions of NE-4C cells obtained from noninduced (0 day)
or RA-treated cultures on the second, fourth, sixth, or eighth
day of cultivation. Protein (10 g) was loaded from both
NE-4C and control forebrain samples (fb). The bands were
visualized by alkalic phosphatase reaction. The upper panel
shows the results obtained by the antibody recognising all
forms of NR1 (pan NR1; Watanabe et al., 1998). A single
protein band at about 116 kDa was detected both in the
cytoplasmic/microsomal and in the crude-membrane frac-
tions of NE-4C cells at all developmental stages. In adult
forebrain homogenates used as controls (fb), double bands
were visible. The lower panel presents data obtained by the
antibody recognizing the C2 cassette of the NR1 rat protein
(C2 exon; Chemicon Ltd). A single protein band at about
116 kDa was demonstrated primarily in the cytoplasmic/
microsomal fractions. (B,C) Immunocytochemical detection
of NR1 subunit in nondifferentiated (B) and in differenti-
ated cells on the seventh day of induction (C). Cells were
stained with either the N-terminal specific antibody (B;
Watanabe et al., 1998) or with Clone 54.1 monoclonal
antibody (C; Pharmingen Ltd) and were visualized by im-
munofluorescent microscopy. The bars indicate 10 m.
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or partly degraded forms of NR2A protein were also
present.
Immunocytochemical staining was carried out ei-
ther by the antibody used for Western blotting, or by
an antibody directed against the 1126–1408 amino
acids of NR2A (Watanabe et al., 1998) (Table 2). The
two antibodies gave similar staining patterns. Fine
grain-like staining was localized evenly over the cy-
toplasm of noninduced progenitor cells [Fig. 3(B)],
while a more diffuse staining was detected in RA-
induced NE-4C neurons, mainly in the perikarya [Fig.
3(C)].
NR2B Subunit Protein Showed a Distinct
Expression Pattern
NR2B protein was detected by the antibody directed
against the 1325–1461 amino acid residues (Laurie et
al., 1997) in Western blot analyses (Table 2). Immu-
noreactive protein bands with an apparent molecular
weight of about 180 kDa were detected in the control
forebrain samples and also in samples of differenti-
ated NE-4C cells [Fig. 3(A)]. Similarly to NR2A
detection, at least 60 g protein of NE-4C samples
was required to get reliable signals.
NR2B immunoreactive bands with a molecular
weight (180 kDa) identical to that seen in the fore-
brain sample were mainly localized in the crude mem-
brane fraction. These specific bands were not detected
earlier than the sixth day of RA induction. On the
ninth day, the majority of NR2B protein was found in
the crude membrane fraction and the relative amount
was similar to that found in the forebrain sample.
In the cytoplasmic fractions obtained from nonin-
duced or from differentiated cells, an immunoreactive
band with a lower (about 160 kDa) apparent molec-
ular weight was found. The amount of the 160-kDa
immunopositive protein increased during the whole
period of differentiation. These bands, however, were
not observed in the crude membrane fraction.
Using an antibody directed against the N-terminal
1–48 amino acids of NR2B (Watanabe et al., 1998)
(Table 2), immunreactivity was demonstrated in both
nondifferentiated and differentiated NE-4C cells [Fig.
3(D)–(E)]. The antibody gave nonhomogeneous, dot-
like staining in noninduced progenitors [Fig. 3(D)].
After the appearance of neurons with long pro-
cesses—from the second week of induction—strong
immunoreactivity was observed in the perikarya and
also in the neurites [Fig. 3(E)].
Although NE-4C cells expressed NR2C mRNA
only transiently, the presence of NR2C protein was
checked by Western blotting. In cerebellar homoge-
nates used as positive control, a single band with
140-kDa apparent molecular weight gave a strong
signal. In NE-4C samples taken from any period of
neuronal differentiation, the subunit could not be de-
tected even if 60 g protein was loaded [Fig. 3(A)].
The commercially available antibody (Santa Cruz
Biotech.) against NR2D failed to detect any specific
protein bands in any samples prepared from NE-4C
cells or 3-day-old forebrain tissue.
Figure 3 NR2A, NR2B, and NR2C subunits in NE-4C
cells at different stages of neuronal differentiation. (A)
Western blot detection of NR2A (upper panel), NR2B (mid-
dle panel), and NR2C (lower panel) subunits in subcellular
fractions of NE-4C cells obtained from non-induced (0) or
RA-treated cultures on the second, fourth, sixth, or ninth
days of cultivation. Lysates of mouse brain: forebrain (fb)
(in the case of NR2A and NR2B detection) or cerebellum
(in the case of NR2C detection) were used as controls.
Protein (60 g) was loaded in each lane and immunoreac-
tion was visualized by ECL method. The specific bands in
the forebrain samples were detected at 170 kDa (NR2A) or
at 180 kDa (NR2B). In the cerebellar samples, NR2C pro-
tein was detected approximately at 140 kDa. (B–E) Immu-
nocytochemical staining of NR2A (B,C) or NR2B (D,E)
subunit in nondifferentiated (B,D) and in differentiated cells
on the seventh (C) or ninth (E) day of induction. Anti-NR2A
(B) and anti-NR2B (D–E) antibodies were gifts from Prof.
Watanabe (Watanabe et al., 1998) or were from Upstate
Biotech (C). Staining was visualized by immunofluorescent
microscopy. Arrows point to the neurites stained by the
antibodies (C,E). The bars indicate 10 m.
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NMDA-Gated Channel Activity Was
Delayed in Comparison to the Detection
of the Subunit Proteins
The appearance of functional NMDA channels during
neuronal differentiation was investigated by mi-
crospectrofluorimetry. The changes in the intracellu-
lar Ca2 level ([Ca2]I) were measured in single cells.
In noninduced, homogeneous cultures, cells were cho-
sen randomly for the analysis. After the appearance of
process-bearing cells in retinoic acid treated cultures,
Ca2 responses were measured only in cells showing
neuron-like morphology.
In noninduced cells or during the first 4 days of
induction, we failed to detect any changes in the
[Ca2]I in response to the addition of 100 M NMDA
(Fig. 4), even under Mg2-free and depolarizing con-
ditions (30 mM KCl; data not shown).
The first NMDA-evoked responses appeared on
the sixth day of induction (Fig. 4), when a large
number of neurons was already present in the cultures
and dense networks of neuronal started to form.
NMDA receptors in NE-4C cells displayed Mg2
sensitivity (data not shown). DL-AP5 (DL-2-Amino-
5-phosphonovaleric acid), a competitive antagonist of
NMDA, could completely block NMDA evoked Ca2
responses (see insert in Fig. 4). With the advancement
of neuronal differentiation, the number of NMDA
responsive cells kept growing (Fig. 4). By the 10th
day, almost all recorded cells gave responses to
NMDA, albeit the amplitude of Ca2 answers varied
considerably.
Addition of specific blockers to voltage-dependent
calcium channels (VDCCs), nifedipine or -cono-
toxin MVIIC, resulted in a partial reduction of
NMDA-induced Ca2 responses (data not shown)
indicating that NMDA-elicited changes stimulated
further Ca influx through VDCCs. To demonstrate the
neuronal maturation of NE-4C cells, the presence of
synaptophysin and synapsin I proteins was investi-
gated. Synaptophysin was not detectable during the
first 4 days of RA treatment by Western blotting [Fig.
5(A)]. Specific signals at an apparent molecular
weight of 38 kDa were detected in the crude mem-
brane fractions from the sixth day on, coinciding in
time with the formation of network of neuronal pro-
cesses.
Synaptophysin was first detected around the seveth
day of induction by immunocytochemical staining.
From this time on, diffuse immunoreactivity was
Figure 4 The relative [Ca2]I rises in noninduced and RA-treated cells, in response to the addition
of 100 M NMDA. Each dot represents the maximum of the Ca-signal recorded from a separate cell
and is presented as the percentage of the resting [Ca2]I in the same cell (100%), detected just before
the addition of NMDA. Insert: a representative NMDA evoked response from a single NE-4C cell
on the sixth day of induction. DL-AP5 (500 M) completely abolished (gray line) the NMDA
evoked [Ca2]I rise (black line).
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found in the perikarya as well as in the neuronal
processes. Varicose processes were stained from the
end of the second week [Fig. 5(B)]. Synapsin I, an-
other characteristic presynaptic marker, was present
in a similar pattern in the perikarya and in the pro-
cesses by the second week of induction [Fig. 5(C)].
DISCUSSION
In the present study, the expression of NMDA recep-
tor subunits and the formation of functional NMDA-
gated ion channels were investigated during retinoic
acid induced in vitro differentiation of NE-4C neuro-
ectodermal progenitor cells. NR1 as well as different
NR2 subunits were demonstrated both at mRNA and
protein level. Despite the early presence of the sub-
units, functional NMDA-gated channels appeared
only later, in parallel with the formation of dense
networks of neuronal processes. Among the NR2 sub-
units, the appearance of NR2B protein showed a re-
markable coincidence in time with the onset of recep-
tor activity. The timing suggested that NMDA
receptor activity required the presence of NR2B sub-
unit and took place only after a defined stage of
neuronal maturation.
In the course of in vitro-induced neuronal differ-
entiation, heterogeneous types of cells developed
from the originally homogeneous NE-4C progenitors.
Also, a number of nondifferentiated progenitors per-
sisted during the entire period of induction (Schlett et
al., 1997; Schlett and Madarasz, 1997). The subunit
expression by noncommitted NE-4C cells therefore
contributed to the subunit pattern displayed by the
cultures in any stage of neuronal induction. Above
this background, the amount of N1 and C1 exon
containing NR1 mRNAs as well as the level of 180-
kDa NR2B protein were specifically elevated in the
course of neuronal differentiation. These changes co-
incided with the formation of NMDA-gated ion chan-
nels and the neuronal maturation of NE-4C cells.
The N1 exon-containing NR1 splice variant was
detected when the first N-tubulin-positive cells ap-
peared and became abundant by the time when dense
networks of neuronal processes were formed (Schlett
et al., 1997; Schlett and Madarasz, 1997). Similar
maturation-dependent shifts from the N1 exon lacking
towards the N1 exon containing transcripts were also
described in vivo and in vitro (Asahi et al., 1998;
Prybylowski et al., 2000). The mass appearance of
NMDA responsive NE-4C neurons also coincided in
time with a prominent increase in the relative amount
of C1 exon containing mRNAs, while the total
amount of C2-containing splice variants did not show
a similar trend. These findings are in accordance with
other observations (Ehlers et al., 1998; Okabe et al.,
1999; Scott et al., 2001) and argue for the potential
regulatory role of C1 exon in the assembly of func-
tional NMDA-gated channels.
NMDA receptor function was not observed before
the appearance of the 180-kDa NR2B protein. NR1
and NR2A subunits, on the other hand, were present
throughout the whole investigated period in the crude
membrane fraction, suggesting that at least a portion
of these subunits was located in the surface mem-
brane. The contradiction between the presence of po-
tential channel forming subunits and the lack of func-
tional receptors argues for control mechanisms
hindering the operation of NMDA receptors before a
certain stage of neuronal differentiation.
Interestingly, we failed to detect a sharp increase in
the amount of the NR1 protein despite the clear-cut
increase in the amount of NR1 mRNAs in the course
of RA-induced development. Moreover, we failed to
detect NR2C protein in NE-4C cultures, even if
NR2C transcripts were observed during the initial
stages of neuronal differentiation. Our findings are in
accordance with data demonstrating that the level of
Figure 5 Expression of synaptic marker proteins in
NE-4C cells at different stages of neuronal differentiation.
(A) Western blot analysis of synaptophysin protein in the
cytoplasmic/microsomal and in the crude membrane frac-
tions obtained from nondifferentiated (0) or RA-treated
NE-4C cells on the second, fourth, sixth, or ninth day of
treatment. Forebrain sample was used as positive control.
Protein (70 g) was loaded from each sample, and detection
was carried out by ECL technique. Strong, specific signal at
the apparent molecular weight of 38 kDa was detected in
samples obtained from the forebrain and from the crude
membrane fractions of NE-4C cells from the sixth day of
induction on. A weaker band appeared also in the cytoplas-
mic samples of NE-4C cells but not sooner than the ninth
day of RA treatment. (B,C) Immunocytochemical detection
of synaptophysin (B) and synapsin I (C) protein in NE-4C
neurons on the 10th (C) or 14th (B) day of induction. The
bars represent 10 m.
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receptor subunit mRNAs does not strictly correlate
with the level of the corresponding subunit proteins
(Sucher et al., 1993; Resink et al., 1995).
Our data argue for the presence of some mecha-
nisms, which seem to regulate the maturation and cell
surface expression of the subunits on a differentiation-
dependent way. C2 exon containing NR1 subunits
were localized mainly in the cytoplasmic fraction.
This observation is in accordance with the hypothesis
that NR1 subunits containing C2 cassette are not
targeted to the cell surface (Chazot and Stephenson,
1997). Although the apparent molecular weight of
NR1 protein in NE-4C samples corresponded to that
found in the adult forebrain, some NR2A and NR2B
immunoreactive bands with a lower (approximately
160 kDa) molecular weight were also detected. The
fact that the intensity of the lower molecular weight
bands increased in the cytoplasmic fraction while it
decreased in the crude membrane fraction argues
against the possibility of nonspecific antibody bind-
ing. Although the partial degradation of the subunits
cannot be ruled out, the lower immunoreactive bands
can also represent immature forms of the subunit
proteins. Unfortunately, we do not have any direct
evidence concerning the glycosylation or phosphory-
lation of these subunits, which are known to influence
the molecular weight of the NR2 subunits (Kennedy,
1997; Laurie et al., 1997). NMDA receptors are be-
lieved to assemble in the endoplasmic reticulum,
where NR2 subunits seem to be the limiting factors in
the coassembly and cell surface targeting of the re-
ceptor complexes (McIlhinney et al., 1996, 1998).
Other observations also support that interactions be-
tween various parts of the NR1 and NR2 subunits are
required for the efficient assembly and trafficking of
the receptor complex (Forrest at al., 1994; Mori et al.,
1998; Sprengel et al., 1998; Steigerwald et al., 2000;
Scott et al., 2001). As in NE-4C cells the majority of
the NR1 protein was found in the cytoplasmic fraction
during all investigated periods, it can be hypothesized
that the assembly and/or the successful transport of
NR1 protein to the cell surface was hindered either by
the presence of the lower molecular weight forms of
NR2 subunits or by the lack of the mature form of
NR2B protein. Further investigations are needed to
determine why no functional NMDA receptors were
detected in NE-4C cells, even if mature forms of
NR2A and NR1 were present. One explanation can be
that the mature form of NR2B subunit is the limiting
factor for receptor functioning in NE-4C cells.
NMDA responsiveness was not observed before
the detection of synapsin I and synaptophysin. The
onset of receptor functioning required a certain stage
of neuronal maturation even if some NR1 and NR2
subunits had already been present. The observed dif-
fuse immunostaining of the presynaptic proteins,
however, indicates that the clustering of these pro-
teins, and consequently, the formation of presynaptic
machineries, did not start at a stage when NMDA
responsiveness had been a general feature of NE-4C
neurons. Our observations prove that NMDA recep-
tors were functional in NE-4C neurons well before the
establishment of synaptic connections.
The schedule of NMDA receptor subunit expres-
sion by NE-4C cells did not strictly correlate with in
vivo patterns described for various regions of the
developing rodent brain (Watanabe et al., 1992; Lau-
rie and Seeburg, 1994; Monyer et al., 1994). NE-4C
progenitors, derived from forebrain vesicles of 9-day-
old embryos, represent an early neuroectodermal phe-
notype. Therefore, the in vitro neurogenesis by
NE-4C cells provides a model system to study mainly
the early steps of pan-neuronal commitment by neu-
roectodermal progenitors but not the more region- and
function-specific neuronal differentiation. Studies car-
ried out on another p53/ embryonic neuroectoder-
mal progenitor line, NE-7C2 (Varju et al., 2001),
demonstrated that while the expression pattern of the
NMDA receptor subunits differed, functional NMDA
channels appeared at a similar stage of in vitro neuron
formation. Studies on neuronally differentiated em-
bryonic stem cells (Stru¨bing et al., 1995; Finley et al.,
1996; Okabe et al., 1996) or P19 EC cells (Morley et
al., 1995; Finley et al., 1996) also indicated that
NMDA-gated ion channels appeared on differentiat-
ing neurons, but only after a defined stage of commit-
ment. Consequently, neural progenitor cell lines are
appropriate objects for studies on the relation between
neuronal cell fate decision and NMDA receptor func-
tioning, even if the data obtained on defined cell lines
necessarily reflect some clone-specific characteristics.
Several cell lines screened for NMDA receptor
expression displayed only a few NMDA receptor sub-
units (Turetsky et al., 1993; Younkin et al., 1993;
Leclerc et al., 1995; Morley et al., 1995; Asahi et al.,
1998). NE-4C cells, on the other hand, expressed all
forms of NR2 mRNAs and several NR1 mRNA splice
variants on a highly reproducible schedule, and many
subunits were present also at the protein level. In
induced NE-4C cells, these processes are controlled
by inherent regulatory machinery. The in vitro in-
duced neuron formation by NE-4C cells can be used
to study the early steps of subunit production, trans-
port, or assembly into functional NMDA receptors in
developmental stages preceding synapse formation.
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